NCT07262567 2025-12-03
Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer
Genfleet Therapeutics (Shanghai) Inc.
Phase 3 Not yet recruiting
Genfleet Therapeutics (Shanghai) Inc.
University of Erlangen-Nürnberg Medical School
Pharmexa A/S